Microsoft word - cv - prof. andrea fabbri

Curriculum Vitae
Andrea Fabbri

Born in Rome 26/08/1956. Degree in Medicine with laude (1980), Specialty in Endocrinology with
laude (1983) and Philosophy Doctor in Endocrinology (1988), University of Rome La Sapienza
University Positions and Clinical Activities:
1990-2001. Assistant Professor in Endocrinology, Dept. of Medical Physiopathology, University La
Sapienza, Rome-Italy
2002- Associate Professor in Endocrinology, Dept. of Internal Medicine, University Tor Vergata,
Rome-Italy
2001- Director UOC of Endocrinology, ASL Roma C - S. Eugenio & CTO A. Alesini Hospital,
Rome-Italy
Scientific Stages and Positions Abroad:
1982-1983. NIH-NIMH, Bethesda (USA) Dr. C.B. Pert
1984-1989. NIH-NICHD, Bethesda (USA) Dr. M.L. Dufau
1998-2000. Senior Lecturer-Honorary Consultant in Endocrinology, Dept. of Endocrinology, Prof.
G.M. Besser, St. Bartholomew's Hospital London
Fellowships and scientific prizes:
1983. Wellcome Stipend Fund from FAES
1988. Bracco Prize from SIE for the PhD thesis
1989. Nato-CNR senior fellowship
Society memberships:
Italian Society of Endocrinology (SIE) - Treasurer,
Italian Society of Andrology and Sexual Medicine (SIAMS) - President of Lazio Section
European Society Sexual Medicine
Endocrine Society
Major fields of interest:
Male reproduction
Adipose tissue
Erectile dysfunction
Androgens in male aging
Osteoporosis
Reviewer of the following journals:
Journal of Endocrinological Investigation
International Journal of Andrology
Clinical Endocrinology
Endocrinology
Journal of Sexual Medicine
PlosOne
Publications:
More than 400 in peer reviewed journals
CURRICULUM VITAE – Prof. Andrea FABBRI
Professore Associato di Endocrinologia
Dipartimento di Medicina Interna, Università di Roma Tor Vergata
Direttore UOC Endocrinologia, Polo Ospedaliero Integrato S. Eugenio & CTO A. Alesini,
Roma
Cell. 338-7126479
Email: [email protected]
Nato a Roma il 26/08/1956. Maturità classica presso l’Istituto Massimiliano Massimo con 60/60 (1974).
Laurea in Medicina e Chirurgia con 110/110 e lode (1980), Università di Roma La Sapienza.
Specializzazione in Endocrinologia con 70/70 (1983), Università di Roma La Sapienza.
Dottorato di Ricerca in Endocrinologia e Metabolismo (1988), Università di Roma La Sapienza.
Posizione Universitaria
1990-2002 Ricercatore, Dip.to Fisiopatologia Medica, Università di Roma La Sapienza
01/11/2002- Professore Associato di Endocrinologia, Università di Roma Tor Vergata
Attività Clinico-Assistenziale
1990-2001 Assistente, S.S. di Andrologia, Dipartimento di Fisiopatologia Medica, Università di Roma La Sapienza
1998-2000 Honorary Consultant in Endocrinologia, St. Bartholomew's Hospital, Londra
2002-2003 Aiuto Ambulatorio di Endocrinologia, Policlinico di Tor Vergata, Università di Roma Tor Vergata
2003-2005 Responsabile UOC Endocrinologia, Ospedale Fatebenefratelli, Isola Tiberina, Roma
2006- Direttore UOC di Endocrinologia, Polo Ospedaliero Integrato S. Eugenio e CTO A. Alesini, Roma
Centro di Riferimento Regionale del Lazio Malattie Rare Endocrine Attività Didattica e Contratti di Insegnamento
1988-89 Titolare del corso: Fisiopatologia della Sessualita' della Facoltà di Medicina, Università La Sapienza.
1989-90 Titolare del corso: Dottrina di Costituzioni Umane di Endocrinologia, ISEF di Roma
1998-2000 Senior Lecturer in Endocrinologia, Dipartimento di Endocrinologia, St. Bartholomew's Hospital, Londra
2001- Professore Associato di Endocrinologia, Università di Roma Tor Vergata
2011-
Esperto del Consiglio Superiore di Sanità Periodi di lavoro all'estero
1978 Endocrinology Dept., St. Bartholomew's Hospital, Prof. GM. Besser, Londra
1982-83 NIH-NIMH, Bethesda, MD, Section on Brain Biochemistry, Dr. C.B Pert.
1984-89 NIH-NICHD, Bethesda, MD, Section Molecular Endocrinology, Dr. M.L. Dufau
1998-2000 Honorary Consultant e Senior Lecturer in Endocrinologia, St. Bartholomew's Hospital, Londra
Borse di Studio e Premi
1983 Wellcome Stipend Fund della FAES
1988 Premio Bracco della Società Italiana di Endocrinologia per la tesi del Dottorato di Ricerca
1989 Borsa NATO-CNR Senior
Affiliazioni a Società
- Società Italiana di Endocrinologia/SIE (Membro Consiglio Direttivo e Tesoriere)
- Endocrine Society
- Società Italiana di Andrologia e Medicina della Sessualità/SIAMS (Presidente della Sezione Lazio)
Interessi di Ricerca Clinica e Sperimentale
-
Disturbi della funzione tiroide/ Obesità/ Osteoporosi Neuroendocrinologia/ Endocrinologia della riproduzione e dell’età evolutiva/ Malattie rare endocrine Pubblicazioni scientifiche
L'attività scientifica si articola in più di 400 pubblicazioni su riviste, libri ed atti di congresso italiani e stranieri con
Impact Factor (IF) attuale di 490. H index = 32
Andrea Fabbri
Principali pubblicazioni (2007-2012)
1: Mammi C, Calanchini M, Antelmi A, Cinti F, Rosano GM, Lenzi A, Caprio M, Fabbri A. Androgens and
adipose tissue in males: a complex and reciprocal
interplay.
Int J Endocrinol. 2012:789653. Epub 2011 Dec 22.
2: Minella D, Wannenes F, Biancolella M, Amati F, Testa B, Nardone A, Bueno S, Fabbri A, Lauro D,
Novelli G, Moretti C. SOS1 over-expression in genital skin
fibroblasts from hirsute women: a putative role of the SOS1/RAS pathway in the pathogenesis of hirsutism.
J Biol Regul Homeost Agents. 2011 Oct-Dec;25(4):615-26.
3: Marzolla V, Armani A, Zennaro MC, Cinti F, Mammi C, Fabbri A, Rosano GM, Caprio M. The role of
the mineralocorticoid receptor in adipocyte biology and fat
metabolism.
Mol Cell Endocrinol. 2012 Mar 24;350(2):281-8. Epub 2011 Sep 10.
4: Giganti MG, Minella D, Testa B, Zenobi R, Biancolella M, Isidori AM, Caprio M, Novelli G, Fabbri A.
A pilot study on the transcriptional response of androgen-
and insulin-related genes in peripheral blood mononuclear cells induced by testosterone administration in
hypogonadal men.
J Biol Regul Homeost Agents. 2011 Apr-Jun;25(2):291-4.
5: Armani A, Marzolla V, Rosano GM, Fabbri A, Caprio M. Phosphodiesterase type 5 (PDE5) in the
adipocyte: a novel player in fat metabolism?
Trends Endocrinol Metab. 2011 Oct;22(10):404-11. Epub 2011 Jul 7
6: Mammi C, Pastore D, Lombardo MF, Ferrelli F, Caprio M, Consoli C, Tesauro M, Gatta L, Fini M,
Federici M, Sbraccia P, Donadel G, Bellia A, Rosano GM, Fabbri
A, Lauro D. Sildenafil reduces insulin-resistance in human endothelial cells.
PLoS One. 2011 Jan 28;6(1):e14542.
7: Franconi G, Manni L, Aloe L, Mazzilli F, Giambalvo Dal Ben G, Lenzi A, Fabbri A. Acupuncture in
clinical and experimental reproductive medicine: a review.
J Endocrinol Invest. 2011 Apr;34(4):307-11. Epub 2011 Feb 4.
8: Aversa A, Caprio M, Antelmi A, Armani A, Brama M, Greco EA, Francomano D, Calanchini M, Spera G,
Di Luigi L, Rosano GM, Lenzi A, Migliaccio S, Fabbri A.
Exposure to phosphodiesterase type 5 inhibitors stimulates aromatase expression in human adipocytes in
vitro.
J Sex Med. 2011 Mar;8(3):696-704.
9: Caprio M, Antelmi A, Chetrite G, Muscat A, Mammi C, Marzolla V, Fabbri A, Zennaro MC, Fève B.
Antiadipogenic effects of the mineralocorticoid receptor
antagonist drospirenone: potential implications for the treatment of metabolicsyndrome.
Endocrinology. 2011 Jan;152(1):113-25. Epub 2010 Nov 17.

10: Mariani S, Basciani S, Fabbri A, Agati L, Ulisse S, Lubrano C, Spera G, Gnessi L. Severe
oligozoospermia in a young man with chronic myeloid leukemia on
long-term treatment with imatinib started before puberty.
Fertil Steril. 2011 Mar 1;95(3):1120.e15-7.
11: Lenzi A, Balercia G, Bellastella A, Colao A, Fabbri A, Foresta C, Galdiero M, Gandini L, Krausz C,
Lombardi G, Lombardo F, Maggi M, Radicioni A, Selice R,
Sinisi AA, Forti G. Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism.
J Endocrinol Invest. 2009 Dec;32(11):934-8. Epub 2009 Dec 1.
12: Jannini EA, Isidori AM, Gravina GL, Aversa A, Balercia G, Bocchio M, Boscaro M, Carani C, Corona
G, Fabbri A, Foresta C, Forti G, Francavilla S, Granata AR,
Maggi M, Mansani R, Palego P, Spera G, Vetri M, Lenzi A; Endotrial Study Group. The ENDOTRIAL
study: a spontaneous, open-label, randomized, multicenter,
crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction.
J Sex Med. 2009 Sep;6(9):2547-60. Epub 2009 Jun 29.
13: Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A, Piccione E. Role of type I
collagen C telopeptide, bone-specific alkaline
phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
J Obstet Gynaecol Res. 2009 Feb;35(1):152-9.
14: Caprio M, Mammi C, Jaffe IZ, Zennaro MC, Aversa A, Mendelsohn ME, Fabbri A, Rosano GM. The
mineralocorticoid receptor in endothelial physiology and disease: novel concepts in the understanding of
erectile dysfunction.
Curr Pharm Des. 2008;14(35):3749-57.
15: Foresta C, Caretta N, Corona G, Fabbri A, Francavilla S, Jannini E, Maggi M, Bettocchi C, Lenzi A.
Clinical and metabolic evaluation of subjects with erectile
dysfunction: a review with a proposal flowchart.
Int J Androl. 2009 Jun;32(3):198-211. Epub 2008 Dec 9.
16: Wannenes F, Caprio M, Gatta L, Fabbri A, Bonini S, Moretti C. Androgen receptor expression during
C2C12 skeletal muscle cell line differentiation.
Mol Cell Endocrinol. 2008 Sep 24;292(1-2):11-9. Epub 2008 Jun 7.
17: Caprio M, Zennaro MC, Fève B, Mammi C, Fabbri A, Rosano G. Potential role of progestogens in the
control of adipose tissue and salt sensitivity via
interaction with the mineralocorticoid receptor.
Climacteric. 2008 Jun;11(3):258-64.
18: Caprio M, Newfell BG, la Sala A, Baur W, Fabbri A, Rosano G, Mendelsohn ME, Jaffe IZ. Functional
mineralocorticoid receptors in human vascular endothelial
cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion.
Circ Res. 2008 Jun 6;102(11):1359-67. Epub 2008 May 8

19: Shabsigh R, Arver S, Channer KS, Eardley I, Fabbri A, Gooren L, Heufelder A, Jones H, Meryn S,
Zitzmann M. The triad of erectile dysfunction, hypogonadism and the metabolic syndrome.
Int J Clin Pract. 2008 May;62(5):791-8. Epub 2008 Feb 2.
20: Shabsigh R, Arver S, Channer KS, Eardley I, Fabbri A, Gooren L, Heufelder A, Jones H, Meryn S,
Zitzmann M. Sexual health as a portal to men's health: a
problem turned around into an opportunity.
Int J Clin Pract. 2008 Feb;62(2):179-81.
21: Aversa A, Vitale C, Volterrani M, Fabbri A, Spera G, Fini M, Rosano GM.
Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes.
Diabet Med. 2008 Jan;25(1):37-44.
22: Fabbri A, Giannetta E, Lenzi A, Isidori AM. Testosterone treatment to mimic hormone physiology in
androgen replacement therapy. A view on testosterone gel
and other preparations available.
Expert Opin Biol Ther. 2007 Jul;7(7):1093-106.

Source: http://medicinainterna.uniroma2.it/medicinainterna.uniroma2.it/medicina_interna/wp-content/uploads/2012/05/CV-Prof.-Andrea-Fabbri.pdf